IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lipella Pharmaceuticals Inc

CUSIP: 53630L100 | 13 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Vanguard Group Inc34,520
0.0% of portfolio›$16.3K
Geode Capital Management, LLC24,915
0.0% of portfolio›$11.8K
HRT Financial LP17,619
0.0% of portfolio›$8
Tower Research Capital LLC (TRC)7,694
0.0% of portfolio›$3.6K
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vanguard Group Inc
34,520$16.3K0.0%N/AN/AValley Forge, PA2024-11-13
Geode Capital Management, LLC
24,915$11.8K0.0%IndexVery LowBoston, MA2024-11-12
HRT Financial LP
17,619$80.0%GARPVery HighNew York, NY2024-11-12
Tower Research Capital LLC (TRC)
7,694$3.6K0.0%GARPVery HighNew York, NY2024-11-14
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2024-10-10